X chromosomal abnormalities in basal-like human breast cancer - PubMed (original) (raw)
X chromosomal abnormalities in basal-like human breast cancer
Andrea L Richardson et al. Cancer Cell. 2006 Feb.
Free article
Abstract
Sporadic basal-like cancers (BLC) are a distinct class of human breast cancers that are phenotypically similar to BRCA1-associated cancers. Like BRCA1-deficient tumors, most BLC lack markers of a normal inactive X chromosome (Xi). Duplication of the active X chromosome and loss of Xi characterized almost half of BLC cases tested. Others contained biparental but nonheterochromatinized X chromosomes or gains of X chromosomal DNA. These abnormalities did not lead to a global increase in X chromosome transcription but were associated with overexpression of a small subset of X chromosomal genes. Other, equally aneuploid, but non-BLC rarely displayed these X chromosome abnormalities. These results suggest that X chromosome abnormalities contribute to the pathogenesis of BLC, both inherited and sporadic.
Similar articles
- X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
Vincent-Salomon A, Ganem-Elbaz C, Manié E, Raynal V, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH, Heard E. Vincent-Salomon A, et al. Cancer Res. 2007 Jun 1;67(11):5134-40. doi: 10.1158/0008-5472.CAN-07-0465. Cancer Res. 2007. PMID: 17545591 - Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.
Ganesan S, Richardson AL, Wang ZC, Iglehart JD, Miron A, Feunteun J, Silver D, Livingston DM. Ganesan S, et al. Cold Spring Harb Symp Quant Biol. 2005;70:93-7. doi: 10.1101/sqb.2005.70.045. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869742 - Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.
Sirchia SM, Ramoscelli L, Grati FR, Barbera F, Coradini D, Rossella F, Porta G, Lesma E, Ruggeri A, Radice P, Simoni G, Miozzo M. Sirchia SM, et al. Cancer Res. 2005 Mar 15;65(6):2139-46. doi: 10.1158/0008-5472.CAN-04-3465. Cancer Res. 2005. PMID: 15781624 - The molecular pathology of hereditary breast cancer.
Palacios J, Robles-Frías MJ, Castilla MA, López-García MA, Benítez J. Palacios J, et al. Pathobiology. 2008;75(2):85-94. doi: 10.1159/000123846. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544963 Review. - The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
Fadare O, Tavassoli FA. Fadare O, et al. Adv Anat Pathol. 2007 Sep;14(5):358-73. doi: 10.1097/PAP.0b013e31814b26fe. Adv Anat Pathol. 2007. PMID: 17717437 Review.
Cited by
- Micro-RNAs in breast cancer progression and metastasis: A chromatin and metabolic perspective.
Sikder S, Bhattacharya A, Agrawal A, Sethi G, Kundu TK. Sikder S, et al. Heliyon. 2024 Sep 20;10(19):e38193. doi: 10.1016/j.heliyon.2024.e38193. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386816 Free PMC article. Review. - Integrative Pan-Cancer Analysis Reveals the Oncogenic Role of MND1 and Validation of MND1's Role in Breast Cancer.
Zhang W, Xiao Y, Zhu X, Zhang Y, Xiang Q, Wu S, Song X, Zhao J, Yuan R, Li Q, Xiao B, Li L. Zhang W, et al. J Inflamm Res. 2024 Jul 17;17:4721-4746. doi: 10.2147/JIR.S458832. eCollection 2024. J Inflamm Res. 2024. PMID: 39051055 Free PMC article. - Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer.
Carey-Smith SL, Kotecha RS, Cheung LC, Malinge S. Carey-Smith SL, et al. Int J Mol Sci. 2024 Jun 21;25(13):6815. doi: 10.3390/ijms25136815. Int J Mol Sci. 2024. PMID: 38999925 Free PMC article. Review. - Systematic proteomics analysis revealed different expression of laminin interaction proteins in breast cancer: lower in luminal subtype and higher in claudin-low subtype.
Gao XL, Pan T, Duan WB, Zhu WB, Liu LK, Liu YL, Yue LL. Gao XL, et al. Transl Cancer Res. 2024 May 31;13(5):2108-2121. doi: 10.21037/tcr-23-2214. Epub 2024 May 29. Transl Cancer Res. 2024. PMID: 38881926 Free PMC article. - Oncogenes and tumor suppressor genes: functions and roles in cancers.
Dakal TC, Dhabhai B, Pant A, Moar K, Chaudhary K, Yadav V, Ranga V, Sharma NK, Kumar A, Maurya PK, Maciaczyk J, Schmidt-Wolf IGH, Sharma A. Dakal TC, et al. MedComm (2020). 2024 May 31;5(6):e582. doi: 10.1002/mco2.582. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38827026 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous